Targovax ASA (GB:0RIS) has released an update.
Damian Marron, Chairman of Circio Holding ASA, has exercised 3,604 subscription rights at NOK 2.50 each and additionally subscribed for 140,000 shares on 5 July 2024, in a move to strengthen his investment as the company moves forward with its innovative RNA therapeutics and cancer vaccine trials.
For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.
